1
|
Cacioppo M, Lucas C, Dai S, Bailly R, Pérennou D, Varengue R, Houx L, Lempereur M, Kandalaft C, Chatelin A, Vagnoni J, Vuillerot C, Gautheron V, Dinomais M, Dheilly E, Bouvier S, Brochard S, Pons C, Mensah-Gourmel J, Génot A, Ropars J, Toullet P, De Lattre C, Klinger E, Laffont I, Sitruk C, Van Boagert P, Tessiot C. Parent satisfaction with medical and rehabilitation services for children with physical disabilities during lockdown. Ann Phys Rehabil Med 2023; 66:101726. [PMID: 36565595 DOI: 10.1016/j.rehab.2022.101726] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/23/2022] [Revised: 11/01/2022] [Accepted: 11/04/2022] [Indexed: 12/24/2022]
Affiliation(s)
- Marine Cacioppo
- Service de Médecine Physique et de Réadaptation, CHRU Brest, Brest, France; Fondation Ildys, Brest, France; Laboratoire de Traitement de l'information Médicale (LaTIM), Inserm U1101, Université Bretagne Occidentale, Brest, France.
| | - Clémence Lucas
- Service de Médecine Physique et de Réadaptation, CHRU Brest, Brest, France
| | - Shenhao Dai
- Département de NeuroRéhabilitation Hôpital Sud, CHU Grenoble Alpes ; UMR CNRS 5105 Neuropsychologie et NeuroCognition,Université de Grenoble Alpes, Grenoble, France
| | - Rodolphe Bailly
- Fondation Ildys, Brest, France; Laboratoire de Traitement de l'information Médicale (LaTIM), Inserm U1101, Université Bretagne Occidentale, France
| | - Dominic Pérennou
- Département de NeuroRéhabilitation Hôpital Sud, CHU Grenoble Alpes ; UMR CNRS 5105 Neuropsychologie et NeuroCognition,Université de Grenoble Alpes, Grenoble, FranceDépartement de NeuroRéhabilitation Hôpital Sud, Université de Grenoble Alpes, UMR CNRS 5105 Neuropsychologie et NeuroCognition, CHU Grenoble Alpes, Cs 10217, Grenoble Cedex 9 38043, France
| | - Roxane Varengue
- Département de Neurologie Pédiatrique, CHU Angers, Angers, France
| | - Laetitia Houx
- Service de Médecine Physique et de Réadaptation, CHRU Brest, Brest, France; Fondation Ildys, Brest, France; Laboratoire de Traitement de l'information Médicale (LaTIM), Inserm U1101, Université Bretagne Occidentale, France
| | - Mathieu Lempereur
- Service de Médecine Physique et de Réadaptation, CHRU Brest, Brest, France; Laboratoire de Traitement de l'information Médicale (LaTIM), Inserm U1101, Université Bretagne Occidentale, France
| | | | | | - Jacky Vagnoni
- Fédération Française des Associations d'Infirmes Moteurs Cérébraux, France
| | - Carole Vuillerot
- Service de Médecine Physique et de Réadaptation Pédiatrique, Hôpital Mère-Enfant, Hospices Civils de Lyon, Bron 69500, France; Institut Neuromyogène CNRS UMR 5310 INSERM U1217, Université de Lyon, Lyon, France
| | - Vincent Gautheron
- Service de Médecine Physique et de Réadaptation Pédiatrique, CHU Saint-Etienne, Saint-Etienne, France; UJM Saint-Etienne, Laboratoire Interuniversitaire de Biologie de la Motricité, EA7424, Université de Lyon, Saint-Etienne, France
| | - Mickael Dinomais
- Service de Médecine Physique et de Réadaptation, CHU Angers -Les Capucins, Angers, France; Laboratoire Angevin de Recherche en Ingénierie des Systèmes (LARIS) EA7315, Université d'Angers, Angers, France
| | - Elea Dheilly
- Service de Médecine Physique et de Réadaptation, CHRU Brest, Brest, France; Fondation Ildys, Brest, France; Laboratoire de Traitement de l'information Médicale (LaTIM), Inserm U1101, Université Bretagne Occidentale, France
| | - Sandra Bouvier
- Service de Médecine Physique et de Réadaptation, CHRU Brest, Brest, France; Laboratoire de Traitement de l'information Médicale (LaTIM), Inserm U1101, Université Bretagne Occidentale, France
| | - Sylvain Brochard
- Service de Médecine Physique et de Réadaptation, CHRU Brest, Brest, France; Fondation Ildys, Brest, France; Laboratoire de Traitement de l'information Médicale (LaTIM), Inserm U1101, Université Bretagne Occidentale, France
| | - Christelle Pons
- Service de Médecine Physique et de Réadaptation, CHRU Brest, Brest, France; Fondation Ildys, Brest, France; Laboratoire de Traitement de l'information Médicale (LaTIM), Inserm U1101, Université Bretagne Occidentale, France
| | -
- Service de Médecine Physique et de Réadaptation, CHRU Brest, Brest, France; Fondation Ildys, Brest, France; Laboratoire de Traitement de l'information Médicale (LaTIM), Inserm U1101, Université Bretagne Occidentale, France
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
2
|
Vuillerot C, Girardot F, Payan C, Fermanian J, Iwaz J, De Lattre C, Berard C. Monitoring changes and predicting loss of ambulation in Duchenne muscular dystrophy with the Motor Function Measure. Dev Med Child Neurol 2010; 52:60-5. [PMID: 19453691 DOI: 10.1111/j.1469-8749.2009.03316.x] [Citation(s) in RCA: 77] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
AIM To assess changes in motor function in patients with Duchenne muscular dystrophy using the Motor Function Measure (MFM). METHOD Three studies were performed. Two studies included only physiotherapy-treated patients, with 13 patients (males mean age 11y 7mo, SD 1y 10mo, range 8-14y) in the 3-month study and 41 patients (males mean age 14y 1mo, SD 5y 5mo, range 6-32y) in the 1-year study. A third study compared 12 patients treated with steroids with 12 age- and motor-function-matched untreated patients (males mean age of treated patients 10y 2mo, SD 2y 2mo range 6-14) over a 12-month period. RESULTS Over 3 months, the MFM D1 subscore (standing and transfers) decreased significantly (-4.7%; p<0.01). Over 1 year, all MFM subscores decreased significantly: -4.9% for D1 (p<0.01); -7.7% for D2 (axial and proximal motor capacity; p<0.01); -4.3% for D3 (distal motor capacity; p=0.03); and -5.8% for the total score (p<0.01). A threshold value for loss of ambulation and a predictive value 1 year before loss were estimated (total score 70% and D1 subscore 40%). Compared with the controls, patients treated with steroids had more stable total scores (-0.59 vs -5.87; p=0.02) and D2 subscores (0.98 vs -8.50; p<0.01). INTERPRETATION These results support the use of the MFM in everyday patient management to prepare for loss of ambulation and in clinical trials to follow up patients receiving various treatments.
Collapse
Affiliation(s)
- Carole Vuillerot
- Hospices Civils de Lyon, Department of Pediatric Rehabilitation, Lyon, France.
| | | | | | | | | | | | | |
Collapse
|